Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Paragon 28 Inc (FNA)

Paragon 28 Inc (FNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 800,043
  • Shares Outstanding, K 82,906
  • Annual Sales, $ 216,390 K
  • Annual Income, $ -47,840 K
  • 60-Month Beta 1.01
  • Price/Sales 3.73
  • Price/Cash Flow N/A
  • Price/Book 4.49
Trade FNA with:

Options Overview Details

View History
  • Implied Volatility 72.47% ( -0.38%)
  • Historical Volatility 86.60%
  • IV Percentile 91%
  • IV Rank 73.62%
  • IV High 98.13% on 10/19/23
  • IV Low 0.88% on 08/10/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 107
  • Put/Call OI Ratio 0.97
  • Today's Open Interest 3,835
  • Open Int (30-Day) 2,796

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.11
  • Number of Estimates 2
  • High Estimate -0.09
  • Low Estimate -0.13
  • Prior Year -0.11
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.32 +5.04%
on 03/22/24
12.50 -21.68%
on 03/28/24
+0.13 (+1.35%)
since 03/19/24
3-Month
8.80 +11.25%
on 03/18/24
14.79 -33.81%
on 02/12/24
-1.49 (-13.21%)
since 01/19/24
52-Week
7.95 +23.14%
on 10/26/23
19.72 -50.35%
on 05/05/23
-8.14 (-45.40%)
since 04/19/23

Most Recent Stories

More News
Paragon 28, Inc. (FNA) Reports Q1 Loss, Tops Revenue Estimates

Paragon 28, Inc. (FNA) delivered earnings and revenue surprises of -10% and 3.53%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

FNA : 9.85 (+2.07%)
MLAB : 101.55 (+1.94%)
Paragon 28 Reports First Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance

Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or "Company”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter...

FNA : 9.85 (+2.07%)
Paragon 28 to Present at the Bank of America Securities 2023 Healthcare Conference

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO,...

FNA : 9.85 (+2.07%)
Paragon 28 Launches Phantom® Metatarsal Shortening System

Paragon 28, Inc. (NYSE: FNA), is pleased to announce the launch of its Phantom® Metatarsal Shortening System which features a first in-kind intramedullary device for fixation of in-line shortening osteotomies...

FNA : 9.85 (+2.07%)
Paragon 28 To Report First Quarter Financial Results on May 4, 2023

Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the first quarter...

FNA : 9.85 (+2.07%)
Paragon 28, Inc. (FNA) Reports Q4 Loss, Tops Revenue Estimates

Paragon 28, Inc. (FNA) delivered earnings and revenue surprises of -466.67% and 2.03%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

FNA : 9.85 (+2.07%)
KRMD : 2.13 (+3.40%)
Paragon 28 Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance

Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter and year ended...

FNA : 9.85 (+2.07%)
Paragon 28 to Present at Upcoming Investor Conferences

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO,...

FNA : 9.85 (+2.07%)
OrthoPediatrics (KIDS) Reports Q4 Loss, Lags Revenue Estimates

OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -45.45% and 0.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

KIDS : 30.49 (+3.50%)
FNA : 9.85 (+2.07%)
Earnings Preview: Paragon 28, Inc. (FNA) Q4 Earnings Expected to Decline

Paragon 28, Inc. (FNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FNA : 9.85 (+2.07%)
KIDS : 30.49 (+3.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo.

See More

Key Turning Points

3rd Resistance Point 10.21
2nd Resistance Point 10.08
1st Resistance Point 9.86
Last Price 9.85
1st Support Level 9.51
2nd Support Level 9.38
3rd Support Level 9.16

See More

52-Week High 19.72
Fibonacci 61.8% 15.22
Fibonacci 50% 13.83
Fibonacci 38.2% 12.45
Last Price 9.85
52-Week Low 7.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar